These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Vaccine platforms for the prevention of Lassa fever. Purushotham J; Lambe T; Gilbert SC Immunol Lett; 2019 Nov; 215():1-11. PubMed ID: 31026485 [TBL] [Abstract][Full Text] [Related]
24. Lassa Fever Natural History and Clinical Management. Grant DS; Samuels RJ; Garry RF; Schieffelin JS Curr Top Microbiol Immunol; 2023; 440():165-192. PubMed ID: 37106159 [TBL] [Abstract][Full Text] [Related]
25. Immunogenetics, sylvatic plague and its vectors: insights from the pathogen reservoir Mastomys natalensis in Tanzania. Haikukutu L; Lyaku JR; Lyimo CM; Eiseb SJ; Makundi RH; Olayemi A; Wilhelm K; Müller-Klein N; Schmid DW; Fleischer R; Sommer S Immunogenetics; 2023 Dec; 75(6):517-530. PubMed ID: 37853246 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of Lassa virus among rodents trapped in three South-South States of Nigeria. Agbonlahor DE; Erah A; Agba IM; Oviasogie FE; Ehiaghe AF; Wankasi M; Eremwanarue OA; Ehiaghe IJ; Ogbu EC; Iyen RI; Abbey S; Tatfeng MY; Uhunmwangho J J Vector Borne Dis; 2017; 54(2):146-150. PubMed ID: 28748835 [TBL] [Abstract][Full Text] [Related]
27. Mapping the zoonotic niche of Lassa fever in Africa. Mylne AQ; Pigott DM; Longbottom J; Shearer F; Duda KA; Messina JP; Weiss DJ; Moyes CL; Golding N; Hay SI Trans R Soc Trop Med Hyg; 2015 Aug; 109(8):483-92. PubMed ID: 26085474 [TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study. Grant DS; Engel EJ; Roberts Yerkes N; Kanneh L; Koninga J; Gbakie MA; Alhasan F; Kanneh FB; Kanneh IM; Kamara FK; Momoh M; Yillah MS; Foday M; Okoli A; Zeoli A; Weldon C; Bishop CM; Zheng C; Hartnett J; Chao K; Shore K; Melnik LI; Mucci M; Bond NG; Doyle P; Yenni R; Podgorski R; Ficenec SC; Moses L; Shaffer JG; Garry RF; Schieffelin JS PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010938. PubMed ID: 36758101 [TBL] [Abstract][Full Text] [Related]
29. Movement Patterns of Small Rodents in Lassa Fever-Endemic Villages in Guinea. Mariën J; Kourouma F; Magassouba N; Leirs H; Fichet-Calvet E Ecohealth; 2018 Jun; 15(2):348-359. PubMed ID: 29572697 [TBL] [Abstract][Full Text] [Related]
30. At Home with Bonwitt J; Sáez AM; Lamin J; Ansumana R; Dawson M; Buanie J; Lamin J; Sondufu D; Borchert M; Sahr F; Fichet-Calvet E; Brown H Am J Trop Med Hyg; 2017 Apr; 96(4):935-943. PubMed ID: 28167603 [TBL] [Abstract][Full Text] [Related]
31. Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals. Demby AH; Inapogui A; Kargbo K; Koninga J; Kourouma K; Kanu J; Coulibaly M; Wagoner KD; Ksiazek TG; Peters CJ; Rollin PE; Bausch DG Vector Borne Zoonotic Dis; 2001; 1(4):283-97. PubMed ID: 12653128 [TBL] [Abstract][Full Text] [Related]
32. Lassa virus diversity and feasibility for universal prophylactic vaccine. Lukashevich IS; Paessler S; de la Torre JC F1000Res; 2019; 8():. PubMed ID: 30774934 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology of Lassa Fever. Bell-Kareem AR; Smither AR Curr Top Microbiol Immunol; 2023; 440():87-109. PubMed ID: 33861373 [TBL] [Abstract][Full Text] [Related]
34. Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions. Arruda LB; Free HB; Simons D; Ansumana R; Elton L; Haider N; Honeyborne I; Asogun D; McHugh TD; Ntoumi F; Zumla A; Kock R PLOS Glob Public Health; 2023; 3(11):e0002159. PubMed ID: 37939051 [TBL] [Abstract][Full Text] [Related]
35. In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever. Baral P; Pavadai E; Gerstman BS; Chapagain PP Sci Rep; 2020 May; 10(1):7667. PubMed ID: 32376973 [TBL] [Abstract][Full Text] [Related]
36. A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol. Penfold S; Adegnika AA; Asogun D; Ayodeji O; Azuogu BN; Fischer WA; Garry RF; Grant DS; Happi C; N'Faly M; Olayinka A; Samuels R; Sibley J; Wohl DA; Accrombessi M; Adetifa I; Annibaldis G; Camacho A; Dan-Nwafor C; Deha ARE; DeMarco J; Duraffour S; Goba A; Grais R; Günther S; Honvou ÉJJP; Ihekweazu C; Jacobsen C; Kanneh L; Momoh M; Ndiaye A; Nsaibirni R; Okogbenin S; Ochu C; Ogbaini E; Logbo ÉPMA; Sandi JD; Schieffelin JS; Verstraeten T; Vielle NJ; Yadouleton A; Yovo EK; PLoS One; 2023; 18(3):e0283643. PubMed ID: 36996258 [TBL] [Abstract][Full Text] [Related]
37. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF Virol J; 2010 Oct; 7():279. PubMed ID: 20961433 [TBL] [Abstract][Full Text] [Related]
38. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF Virol J; 2011 Oct; 8():478. PubMed ID: 22023795 [TBL] [Abstract][Full Text] [Related]
39. Temporal analysis of Lassa virus infection and transmission in experimentally infected Safronetz D; Rosenke K; Meade-White K; Sloan A; Maiga O; Bane S; Martellaro C; Scott DP; Sogoba N; Feldmann H PNAS Nexus; 2022 Jul; 1(3):pgac114. PubMed ID: 35967978 [TBL] [Abstract][Full Text] [Related]